Beta Bionics, Inc.
NASDAQ:BBNXMedical - Equipment & Services
+$0.42 today
- Market cap
- $644.70M
- Beta
- 3.39
- P/E (TTM)
- -9.1
- EPS (TTM)
- -$1.50
Volume 1.38M
Average 0.99M
BBNX Total Assets
Everything the company owns or controls; equal to total liabilities plus equity.
Beta Bionics, Inc.NASDAQ: BBNX
Total Assets · Q1 FY2026 · quarter ended Mar 2026
Total assets falls 9.9% from a year ago
Total assets stood at $304.42M at the end of Q1 FY2026, down 9.9% from a year earlier and down 7.4% from the prior quarter. Over 3 fiscal years it compounded at +109.9% a year.
Context
- Total assets increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether total assets keeps falling in the next quarterly balance sheet after a -9.9% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Assets history
USD · from the balance sheet
- Latest · FY2025
- 328.74M USD
- Year-over-year change
- +119.7%
- 3-year CAGR
- +109.9%
| Period | Period end | Total Assets | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 328.74M | +119.7% |
| FY2024 | 2024-12-31 | 149.65M | +36.0% |
| FY2023 | 2023-12-31 | 110.04M | +209.7% |
| FY2022 | 2022-12-31 | 35.53M | — |
Total Assets vs competitors
How BBNX compares with its peers on the latest reported figures
- Peers report in different currencies, so total assets is compared through growth and rates rather than absolute size.
- Its year-over-year change of -9.9% is the 6th highest of 7, against a peer median of +24.2%.
- Over three fiscal years its annual growth of +109.9% compares with a peer median of +12.5%.
| Company | Period | Latest balance | YoY | 3-year CAGR |
|---|---|---|---|---|
| Jun 2026 | DKK 594.94B DKK | +23.4% | +31.0% | |
| Jun 2026 | $6.46B USD | -11.9% | +5.5% | |
MMEDMiniMed Group, Inc. Common Stock | Jul 2026 | $4.72B USD | — | — |
| Jun 2026 | $3.17B USD | -8.8% | +12.3% | |
| Mar 2026 | $1.15B USD | +25.1% | -5.8% | |
| Mar 2026 | $744.4M USD | +81.5% | +39.0% | |
| Mar 2026 | $304.42M USD | -9.9% | +109.9% | |
| Mar 2026 | $268.85M USD | +82.2% | +12.6% | |
| Peer median (excluding BBNX) | — | +24.2% | +12.5% | |
Competitors are the stored peer set for BBNX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Beta Bionics, Inc.
NASDAQ:BBNX
Intrinsic Alpha fair value
Locked
Current Price
$14.33
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.